Forkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure
Overview
Authors
Affiliations
Objective: Adipose tissue serves as an integrator of various physiological pathways, energy balance, and glucose homeostasis. Forkhead box-containing protein O subfamily (FoxO) 1 mediates insulin action at the transcriptional level. However, physiological roles of FoxO1 in adipose tissue remain unclear.
Research Design And Methods: In the present study, we generated adipose tissue-specific FoxO1 transgenic mice (adipocyte protein 2 [aP(2)]-FLAG-Delta 256) using an aP(2) promoter/enhancer and a mutant FoxO1 (FLAG Delta 256) in which the carboxyl terminal transactivation domain was deleted. Using these mice, we analyzed the effects of the overexpression of FLAG Delta 256 on glucose metabolism and energy homeostasis.
Results: The aP(2)-FLAG-Delta 256 mice showed improved glucose tolerance and insulin sensitivity accompanied with smaller-sized adipocytes and increased adiponectin (adipoq) and Glut 4 (Slc2a4) and decreased tumor necrosis factor alpha (Tnf) and chemokine (C-C motif) receptor 2 (Ccr2) gene expression levels in white adipose tissue (WAT) under a high-fat diet. Furthermore, the aP(2)-FLAG-Delta 256 mice had increased oxygen consumption accompanied with increased expression of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1 alpha protein and uncoupling protein (UCP)-1 (Ucp1), UCP-2 (Ucp2), and beta 3-AR (Adrb3) in brown adipose tissue (BAT). Overexpression of FLAG Delta 256 in T37i cells, which are derived from the hibernoma of SV40 large T antigen transgenic mice, increased expression of PGC-1 alpha protein and Ucp1. Furthermore, knockdown of endogenous FoxO1 in T37i cells increased Pgc1 alpha (Ppargc1a), Pgc1 beta (Ppargc1b), Ucp1, and Adrb3 gene expression.
Conclusions: These data suggest that FoxO1 modulates energy homeostasis in WAT and BAT through regulation of adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake.
Melnik B, Weiskirchen R, Stremmel W, John S, Schmitz G Nutrients. 2024; 16(15).
PMID: 39125332 PMC: 11314333. DOI: 10.3390/nu16152451.
Shi L, Yang J, Tao Z, Zheng L, Bui T, Alonso R Clin Sci (Lond). 2024; 138(6):371-385.
PMID: 38469619 PMC: 10932742. DOI: 10.1042/CS20230973.
A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications.
Huang P, Wang Q, Chen R, Wang Y, Wang Y, Liu J Curr Mol Med. 2024; 25(1):13-26.
PMID: 38289639 DOI: 10.2174/0115665240270426231123155924.
The secreted peptide BATSP1 promotes thermogenesis in adipocytes.
Cui X, Zhong H, Wu Y, Zhang Z, Zhang X, Li L Cell Mol Life Sci. 2023; 80(12):377.
PMID: 38010450 PMC: 10682272. DOI: 10.1007/s00018-023-05027-9.
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.
Teaney N, Cyr N Front Endocrinol (Lausanne). 2023; 14:1286838.
PMID: 37941908 PMC: 10629996. DOI: 10.3389/fendo.2023.1286838.